Arnold Library

RIT-NMAT: A New Hope for High-Risk Lymphoma Patients

Frost, Sophia (2015) RIT-NMAT: A New Hope for High-Risk Lymphoma Patients. Science Spotlight, 5 (1).

RIT-NMAT- A New Hope for High-Risk Lymphoma Patients.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (308Kb) | Preview
Article URL:
Item Type: Article
Additional Information: Cassaday RD, Storer BE, Sorror ML, Sandmaier BM, Guthrie KA, Maloney DG, Rajendran JG, Pagel JM, Flowers ME, Green DJ, Rezvani AR, Storb RF, Press OW, Gopal AK. 2014. Long-term outcomes of patients with persistent indolent B-cell malignancies undergoing nonmyeloablative allogeneic transplantation. Biol Blood Marrow Transplant. [Epub ahead of print] See also: Gopal AK, Guthrie KA, Rajendran J, Pagel JM, Oliveira G, Maloney DG, Matesan MC, Storb RF, Press OW. 2011. 90Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma. Blood. 118(4):1132–1139.
Collections: Science Spotlight
Depositing User: Ben Abraham
Date Deposited: 10 Apr 2015 22:32
Last Modified: 10 Apr 2015 22:32

Repository Administrators Only

View Item View Item
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy